Tec protein tyrosine kinase inhibits CD25 expression in human T-lymphocyte

Immunology Letters

Volumn 127, Issue 2, 2010, Pages 135-142

  Susaki, Kentaro ^a   Kitanaka, Akira ^a   Dobashi, Hiroaki ^a   Kubota, Yoshitsugu ^a   Kittaka, Katsuharu ^a   Kameda, Tomohiro ^a   Yamaoka, Genji ^a   Mano, Hiroyuki ^b   Mihara, Keichiro ^c   Ishida, Toshihiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CD25; T lymphocyte; Tec

Indexed keywords

CD28 ANTIGEN; CELL MARKER; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MOLECULAR MARKER; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE TEC; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STABLE TRANSFECTION; T LYMPHOCYTE; WILD TYPE;

AMIDES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CLONING, MOLECULAR; DOWN-REGULATION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NITRILES; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE DELETION; T-LYMPHOCYTES; TRANSFECTION;

EID: 71949100147     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.10.009     Document Type: Article

References (38)

1. Kane L.P., Lin J., and Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol 12 (2000) 242-249
2. Wang L.D., and Clark M.R. B-cell antigen-receptor signalling in lymphocyte development. Immunology 110 (2003) 411-420
3. Kawakami Y., Yao L., Han W., and Kawakami T. Tec family protein-tyrosine kinases and pleckstrin homology domains in mast cells. Immunol Lett 54 (1996) 113-117
4. Miller A.T., and Berg L.J. New insights into the regulation and functions of Tec family tyrosine kinases in the immune system. Curr Opin Immunol 14 (2002) 331-340
5. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., et al. Defective B cell development and function in Btk-deficient mice. Immunity 3 (1995) 283-299
6. Kerner J.D., Appleby M.W., Mohr R.N., Chien S., Rawlings D.J., Maliszewski C.R., et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3 (1995) 301-312
7. Vetrie D., Vorechovský I., Sideras P., Holland J., Davies A., Flinter F., et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361 (1993) 226-233
8. Tsukada S., Saffran D.C., Rawlings D.J., Parolini O., Allen R.C., Klisak I., et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72 (1993) 279-290
9. Thomas J.D., Sideras P., Smith C.I.E., Vorechovsky I., Chapman V., and Paul W.E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261 (1993) 355-358
10. Rawlings D.J., Saffran D.C., Tsukada S., Largaespada D.A., Grimaldi J.C., Cohen L., et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261 (1993) 358-361
11. Liao X.C., and Littman D.R. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3 (1995) 757-769
12. Liu K.Q., Bunnell S.C., Gurniak C.B., and Berg L.J. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med 187 (1998) 1721-1727
13. Kitanaka A., Mano H., Conley M.E., and Campana D. Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells. Blood 91 (1998) 940-948
14. Ellmeier W., Jung S., Sunshine M.J., Hatam F., Xu Y., Baltimore D., et al. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J Exp Med 192 (2000) 1611-1624
15. Tanaka N., Abe H., Yagita H., Okumura K., Nakamura M., and Sugamura K. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat. Eur J Immunol 27 (1997) 834-841
16. Debnath J., Chamorro M., Czar M.J., Schaeffer E.M., Lenardo M.J., Varmus H.E., et al. rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol Cell Biol 19 (1999) 1498-1507
17. Yang W.C., Ghiotto M., Barbarat B., and Olive D. The role of Tec protein-tyrosine kinase in T cell signaling. J Biol Chem 274 (1999) 607-617
18. August A., Gibson S., Kawakami Y., Kawakami T., Mills G.B., and Dupont B. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci USA 91 (1994) 9347-9351
19. Yang W.C., Ching K.A., Tsoukas C.D., and Berg L.J. Tec kinase signaling in T cells is regulated by phosphatidylinositol 3-kinase and the Tec pleckstrin homology domain. J Immunol 166 (2001) 387-395
20. Tomlinson M.G., Kane L.P., Su J., Kadlecek T.A., Mollenauer M.N., and Weiss A. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Mol Cell Biol 24 (2004) 2455-2466
21. Yamashita Y., Watanabe S., Miyazato A., Ohya K., Ikeda U., Shimada K., et al. Tec and Jak2 kinases cooperate to mediate cytokine-driven activation of c-fos transcription. Blood 91 (1998) 1496-1507
22. Kitanaka A., Suzuki T., Ito C., Nishigaki H., Coustan-Smith E., Tanaka T., et al. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. J Immunol 162 (1999) 1952-1958
23. Dobashi H., Sato M., Tanaka T., Tokuda M., and Ishida T. Growth hormone restores glucocorticoid-induced T cell suppression. FASEB J 15 (2001) 1861-1863
24. Kubota Y., Tanaka T., Kitanaka A., Ohnishi H., Okutani Y., Waki M., et al. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J 20 (2001) 5666-5677
25. Sato K., Mano H., Ariyama T., Inazawa J., Yazaki Y., and Hirai H. Molecular cloning and analysis of the human Tec protein-tyrosine kinase. Leukemia 8 (1994) 1663-1672
26. Yang W.C., Ghiotto M., Castellano R., Collette Y., Auphan N., Nunès J.A., et al. Role of Tec kinase in nuclear factor of activated T cells signaling. Int Immunol 12 (2000) 1547-1552
27. Yang W.C., and Olive D. Tec kinase is involved in transcriptional regulation of IL-2 and IL-4 in the CD28 pathway. Eur J Immunol 29 (1999) 1842-1849
28. Taniguchi T., and Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 73 (1993) 5-8
29. Kim H.P., Imbert J., and Leonard W.J. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 17 (2006) 349-366
30. Mahajan S., Ghosh S., Sudbeck E.A., Zheng Y., Downs S., Hupke M., et al. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide]. J Biol Chem 274 (1999) 9587-9599
31. Yang W.C., Collette Y., Nunès J.A., and Olive D. Tec kinases: a family with multiple roles in immunity. Immunity 12 (2000) 373-382
32. Berg L.J., Finkelstein L.D., Lucas J.A., and Schwartzberg P.L. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol 23 (2005) 549-600
33. Schaeffer E.M., Debnath J., Yap G., McVicar D., Liao X.C., Littman D.R., et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284 (1999) 638-641
34. Kurosaki T. Regulation of B-cell signal transduction by adaptor proteins. Nat Rev Immunol 2 (2002) 354-363
35. Takesono A., Finkelstein L.D., and Schwartzberg P.L. Beyond calcium: new signaling pathways for Tec family kinases. J Cell Sci 115 (2002) 3039-3048
36. Lucas J.A., Felices M., Evans J.W., and Berg L.J. Subtle defects in pre-TCR signaling in the absence of the Tec kinase Itk. J Immunol 179 (2007) 7561-7567
37. 2+ following B-cell receptor activation. EMBO J 17 (1998) 1973-1985
38. Conley M.E., Rohrer J., Rapalus L., Boylin E.C., and Minegishi Y. Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol Rev 178 (2000) 75-90